Hypothalamic-Pituitary-Adrenal Axis Dysfunction in Alzheimer's Disease: Lack of Association Between Longitudinal and Cross-Sectional Findings
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors examined longitudinal hypothalamic-pituitary-adrenal (HPA) axis function in Alzheimer's disease. METHOD: Cortisol levels of 30 patients with Alzheimer's disease and 17 healthy elderly subjects were measured before and after administration of dexamethasone. These measures were repeated at 9-month intervals in the patients with Alzheimer's disease. RESULTS: At baseline, cortisol levels were higher in the Alzheimer's disease group before and after dexamethasone administration. Although only two of the four patients whose cortisol levels were not suppressed by dexamethasone also had high cortisol levels before dexamethasone administration, basal and postdexamethasone cortisol levels were correlated. HPA axis dysfunction correlated with severity of dementia at baseline but was not stable longitudinally and did not increase with follow-up. CONCLUSIONS: There was no association between longitudinal and cross-sectional findings. The longitudinal data were not consistent with a role for the glucocorticoid cascade hypothesis (that hippocampal cell loss in Alzheimer's disease results in hypercortisolism, which in turn acts as a co-factor in further degeneration) in the pathophysiology of mild and moderate Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090
Research works printed but not linked: 16
- Spar JE, Gerner R: Does the dexamethasone test distinguish dementia from depression? Am J Psychiatry 1982; 139:238–240 · DOI · Paper page
- Raskind M, Peskind E, Rivard M-F, Veith R, Barnes R: Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry 1982; 139:1468–1471 · DOI · Paper page
- Balldin J, Gottfries C-G, Karlsson I, Lindsted TG, Långström G, Wålinder J: Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry 1983; 143:277–281 · DOI · Paper page
- McKeith IG: Clinical use of the DST in a psychogeriatric population. Br J Psychiatry 1984; 145:389–393 · DOI
- Jenike MA, Albert MS: The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type. J Am Geriatr Soc 1984; 32:441–444 · DOI · Paper page
- Greenwald BS, Mathé AA, Mohs RC, Levy MI, Johns CA, Davis KL: Cortisol and Alzheimer's disease, II: dexamethasone suppression, dementia severity, and affective symptoms. Am J Psychiatry 1986; 143:442–446 · DOI · Paper page
- Ferrier IN, Pascual J, Charlton BG, Wright C, Leake A, Griffiths HW, Fairbairn AF, Edwardson JA: Cortisol, ACTH, and dexamethasone concentrations in a psychogeriatric population. Biol Psychiatry 1988; 23:252–260 · DOI
- Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathé AA, Johns CA, Horvath TB: Cortisol and Alzheimer's disease, I: basal studies. Am J Psychiatry 1986; 143:300–305 · DOI · Paper page
- Sapolsky RM, Altmann J: Increase of hypercortisolism and dexamethasone resistance increases with age among wild baboons. Biol Psychiatry 1991; 30:1008–1016 · DOI · Paper page
- Ferrier N, Lister ES, Riordan DM, Scott JL, Lett DJ, Leake A, McKeith IG: A follow-up study of elderly depressives and Alzheimer-type dementia—relationship with DST status. Int J Geriatr Psychiatry 1991; 6:279–286 · DOI
- Weiner MF, Vobach S, Svetlik D, Risser RC: Cortisol secretion and Alzheimer's disease progression: a preliminary report. Biol Psychiatry 1993; 34:158–161 · DOI
- Miller AH, Sastry G, Speranza AJ Jr, Lawlor BA, Mohs RC, Ryan TM, Gabriel SM, Serby M, Schmeidler J, Davis KL: Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. Am J Psychiatry 1994; 151:267–270 · DOI · Paper page
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939–944 · DOI · Paper page
- Folstein MF, Folstein SE, McHugh PR: “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198 · DOI · Paper page
- Ball MJ, Fisman M, Hachinski V, Blume W, Fox A, Kral VA, Kirshen AJ, Fox H, Merskey H: A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985; 1:14–16 · DOI · Paper page
- Swanwick GRJ, Coen RF, Walsh JB, Coakley D, Lawlor BA: The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease. Biol Psychiatry 1996; 39:976–978 · DOI
Cited by
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171
The stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
“…as a group, Alzheimer patients have a mildly increased HPA-axis activity, but the increased baseline cortisol levels were not stable longitudinally and did not increase when followed up at later timepoints , which is not consistent with the glucocorticoid cascade hypothesis (Swanwick et al., 1998).”
ResultGlucocorticoids increase amyloid-β and tau pathology in a mouse model of alzheimer’s disease
Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L., & LaFerla, F. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2797-06.2006 · Cited by 623
The stress system in depression and neurodegeneration: Focus on the human hypothalamus
Bao, A.-M., Meynen, G., & Swaab, D. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 548
Sack, R. L., Auckley, D., Auger, R. R., Carskadon, M. A., Wright, K. P., Vitiello, M. V., & Zhdanova, I. V. (2007) · Sleep · doi:10.1093/sleep/30.11.1484 · Cited by 529
Chronic Stress-induced Hippocampal Vulnerability: The Glucocorticoid Vulnerability Hypothesis
Conrad, C. D. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.6.395 · Cited by 425
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2164 · Cited by 426
Bisht, K., Sharma, K., & Tremblay, M.-È. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.05.003 · Cited by 360
Hatfield, C. F. (2004) · Brain · doi:10.1093/brain/awh129 · Cited by 324
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
Caraci, F., Copani, A., Nicoletti, F., & Drago, F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.022 · Cited by 314
Ghadrdoost, B., Vafaei, A. A., Rashidy-Pour, A., Hajisoltani, R., Bandegi, A. R., Motamedi, F., Haghighi, S., Sameni, H. R., & Pahlvan, S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.012 · Cited by 295
Sexual dimorphism in predisposition to Alzheimer's disease
Fisher, D. W., Bennett, D. A., & Dong, H. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.004 · Cited by 270
Juster, R.-P., Bizik, G., Picard, M., Arsenault-Lapierre, G., Sindi, S., Trepanier, L., Marin, M.-F., Wan, N., Sekerovic, Z., Lord, C., et al. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000289 · Cited by 268
“, 2009) Two studies (Csernansky et al., 2006; Swanwick et al., 1998) found that increased cortisol levels over the years were associated with cognitive decline in individuals with clinical dementia ratings of 0.”
BackgroundInfluentialMICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196
“(1998), where HPA axis dysfunction did not become worse over time and with increased cognitive decline in AD patients (Swanwick et al., 1998).”
BackgroundHuang, C.-W., Lui, C.-C., Chang, W.-N., Lu, C.-H., Wang, Y.-L., & Chang, C.-C. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.12.026 · Cited by 138
Devi, L., Alldred, M. J., Ginsberg, S. D., & Ohno, M. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-34 · Cited by 129
“In any case, our present study combined with others indicates that elevated levels of glucocorticoids found in sporadic AD brains [62-64] may not only be a consequence of the pathology but also play a causal role in triggering b-amyloidogenesis through BACE1 and APP elevations during earlier stages of disease progress…”
ResultPlasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2164 · Cited by 426
Central role of glucocorticoid receptors in Alzheimer's disease and depression
Canet, G., Chevallier, N., Zussy, C., Desrumaux, C., & Givalois, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00739 · Cited by 106
Lesuis, S. L., Weggen, S., Baches, S., Lucassen, P. J., & Krugers, H. J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0101-2 · Cited by 85
Glucocorticoids, synaptic plasticity and Alzheimer’s disease
Klyubin, I., Ondrejcak, T., Hu, N.-W., & Rowan, M. J. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100365 · Cited by 16
Metadata
- Authors
- Swanwick, G. R. J., Kirby, M., Bruce, I., Buggy, F., Coen, R. F., Coakley, D., & Lawlor, B. A.
- Venue
- American Journal of Psychiatry
- Published
- 1998-02-01
- Volume
- 155
- Issue
- 2
- Pages
- 286-289
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1924478105
- Cited by
- 131
- References
- 3
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.